Cochrane Abstracts
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Aspirin or Heparin or Both for Improving Pregnancy Outcomes in Women With Persistent Antiphospholipid Antibodies and Recurrent Pregnancy Loss." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/433348/all/Aspirin_or_heparin_or_both_for_improving_pregnancy_outcomes_in_women_with_persistent_antiphospholipid_antibodies_and_recurrent_pregnancy_loss.
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433348/all/Aspirin_or_heparin_or_both_for_improving_pregnancy_outcomes_in_women_with_persistent_antiphospholipid_antibodies_and_recurrent_pregnancy_loss. Accessed May 18, 2025.
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433348/all/Aspirin_or_heparin_or_both_for_improving_pregnancy_outcomes_in_women_with_persistent_antiphospholipid_antibodies_and_recurrent_pregnancy_loss
Aspirin or Heparin or Both for Improving Pregnancy Outcomes in Women With Persistent Antiphospholipid Antibodies and Recurrent Pregnancy Loss [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 May 18]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/433348/all/Aspirin_or_heparin_or_both_for_improving_pregnancy_outcomes_in_women_with_persistent_antiphospholipid_antibodies_and_recurrent_pregnancy_loss.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss
ID - 433348
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/433348/all/Aspirin_or_heparin_or_both_for_improving_pregnancy_outcomes_in_women_with_persistent_antiphospholipid_antibodies_and_recurrent_pregnancy_loss
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
